Showing 1131-1140 of 2123 results for "".
Endovascular Treatment of Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/endovascular-treatment-of-stroke/30290/Current Efforts and ConsiderationsFDA Filing for Cannabidiol, Data on Diet and Exercise and Brain Aging and Memory, Boston Scientific Indication for DBS
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/fda-filing-for-cannabidiol-data-on-diet-and-excercise-and-brain-aging-and-memory-boston-scientific-indication-for-dbs/30285/Neurology in the Media
https://practicalneurology.com/columns/practice-management/neurology-in-the-media/30322/Where #Neurology and Culture IntersectTelemedicine Outcomes and Performance: The Next Phase in Stroke Care
https://practicalneurology.com/diseases-diagnoses/stroke/telemedicine-outcomes-and-performance-the-next-phase-in-stroke-care/30351/As telemedicine becomes more embedded in the stroke treatment landscape, new efforts to quantify outcomes and performance will help maximize its use.MOC and Physician Burnout
https://practicalneurology.com/columns/practice-management/moc-and-physician-burnout/30405/Treating the Cause, Not the SymptomsNews
https://practicalneurology.com/archives/2015-june/news/30548/Tax Planning: Do I Really Need an Investment Advisor?
https://practicalneurology.com/columns/practice-management/tax-planning-do-i-really-need-an-investment-advisor/30577/The Nine Reasons Physician-Investors Underperform Without Professional ManagementNews
https://practicalneurology.com/columns/practice-management/news/30596/Movement Disorders Focus: Harnessing Existing Drugs to Slow Progression of Parkinson's Disease: The STEADY-PDIII Trial of Isradipine
https://practicalneurology.com/diseases-diagnoses/movement-disorders/harnessing-existing-drugs-to-slow-progression-of-parkinsons-disease-the-steady-pdiii-trial-of-isradipine/30654/Health Law Update: What's Next?
https://practicalneurology.com/columns/practice-management/health-law-update-whats-next/30687/The Independent Payment Advisory Board was tasked with achieving savings in Medicare but has now been gutted by Congress and may never become operational.